Detalhe da pesquisa
1.
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Biol Blood Marrow Transplant
; 21(7): 1230-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25797175
2.
Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation.
Eur J Immunol
; 44(9): 2822-34, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24895051
3.
Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study.
Am J Hematol
; 89(2): 174-80, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123244
4.
Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT).
Hematol Oncol Stem Cell Ther
; 13(4): 202-207, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181176
5.
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biol Blood Marrow Transplant
; 14(11): 1279-87, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18940683
6.
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group.
Leuk Lymphoma
; 57(5): 1067-73, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26693800
7.
In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures.
Haematologica
; 90(4): 459-64, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15820940
8.
Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA.
Leukemia
; 33(3): 771-775, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291333
9.
Residual disease in chronic myeloid leukemia after induction of molecular remission.
N Engl J Med
; 349(15): 1483-4, 2003 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-14534349
10.
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup.
J Clin Oncol
; 30(29): 3604-10, 2012 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22965967
11.
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.
Blood
; 111(3): 1039-43, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17932248
12.
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
Br J Haematol
; 120(2): 281-8, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12542488
13.
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biol Blood Marrow Transplant
; 9(4): 266-72, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12720219